- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01601860
The Maternal and Perinatal Outcomes Associated With the Use of Non-pharmacological in Labor
Evaluation of Maternal and Perinatal Outcomes Associated With the Use of Non-pharmacological in Parturients in Active Phase of Labor
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brazílie
- Professor, Department of Gynecology and Obstetrics, Faculty of Medicine of Ribeirão Preto, University of São Paulo.
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
Agreement of the patient to participate in the study after reading and signing the consent form;
- primigravida;
- Pregnancy unique;
- Gestational age> 37 weeks;
- fetal cephalic presentation;
- chorioamniotic intact membranes;
- spontaneous labor;
- Admission to the beginning of the active phase of dilatation (4 cm cervical dilatation);
- Dynamics between 2 and 4 uterine contractions in ten minutes;
- Lack of maternal and fetal pathologies;
- literate;
- Absence of cognitive problems.
Exclusion Criteria:
Intolerance to non-pharmacological application of resources;
- Increased pain by the woman that prevents the completion of the intervention;
- Want to stop the intervention;
- Suspected acute suffering;
- Indication of cesarean section.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Aktivní komparátor: Control
Active Comparator: Control Group Pregnant women who receive assistance from the routine CRSM MATER care, not being assisted by the physiotherapist, but that will be evaluated at the same time in the intervention group.
|
Other: Routine care Routine care of the institution performed by the staff, without the presence of the researcher that included offering a balanced meal, continuous support with the presence of a partner or family throughout labor, use of oxytocin when prescribed by the staff, use of drug analgesia when requested by the patient.
|
Experimentální: Intervention Group
Experimental: Intervention Group Pregnant women who receive the application the combination of non-pharmacological resources according to cervical dilation: Walking (with cervical dilation between 4 and 5 cm) Alternating stance associated with ENT (cervical dilatation from 6 to 7 cm) Shower (with dilation> 7 cm);
|
Other: Non-pharmacological resources A sequence of non-pharmacological resources were applied to the patient by the researcher according to uterine cervical dilation, as follows:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Number of Participants Who Requested Analgesia During the Active Phase of Childbirth
Časové okno: 10 hours
|
Average uterine cervical dilation of the patient who requested analgesia for pain relief.
Data captured from the medical record by the partograph.
|
10 hours
|
The Moment in Centimeters That Women Requested Analgesia During the Active Phase of Childbirth, Analyzed by Cevical Dilation.
Časové okno: 10 hours
|
Moment when a patient requested analgesia for pain relief. Data captured from the medical record by the partograph. A partogram was used, which is a printed document and allows the registration of all procedures and complications that occurred during labor, showing the conditions of the parturient and the fetus during this phase. This information is noted on a graph that makes it possible to assess all labor and duration. The doctor filled out the partograph and assessed the patient during labor, and she did not know which group belonged to the patient |
10 hours
|
Average Duration of the Expulsive Period When Compared to Groups
Časové okno: Starts with 10 centimeters of dilation until delivery
|
Assess the duration of the expulsion period and compare between groups
|
Starts with 10 centimeters of dilation until delivery
|
Types of Dystocia (Functional, Secondary Stop of Dilation and Fetal Offspring) Between Groups
Časové okno: 10 hours
|
Analyze and compare between the groups the types of dystocia. Dystocia: b.1) Functional dystocia was considered when cervical dilation increased progressively, but with a speed less than 1 centimeter per hour; b.2) Secondary stop of the dilation was considered when there were 2 vaginal touches with the same cervical dilation in an interval of at least two hours, without being total. b.3) Secondary descent stop was considered when, with complete dilation of the uterine cervix, the same height of fetal descent was found in two successive touches with an interval of one hour (Protocol Royal College of Obstetricians and Gynecologists, 2012). |
10 hours
|
Admission Numbers to a Neonatal Intensive Care Unit Between Groups.
Časové okno: 10 hours
|
Consider and compare neonatal admission to an intensive care unit between groups, attracted by the partogram
|
10 hours
|
Number of Newborns With Apgar Scores of 1 and 5 Minutes, Less Than or Greater Than 7.
Časové okno: 10 hours
|
Analyze and compare Apgar scores of the 1-min >7 and 5-min >7, between groups. The APGAR score reflects the degree of fetal maturity and predicts healthy child development. It is a scale that can vary from 0 to 10, which 0 is a bad vitality and 10 is an excellent score. When the APGAR score is below 7, especially in the fifth minute, it is a warning sign to give special attention to the newborn. Newborns who have an Apgar in the first minute greater than 7, demonstrate good birth conditions. |
10 hours
|
Frequency of Suspected Fetal Distress, Between Groups
Časové okno: 10 hours
|
Evaluate the frequency of suspected fetal distress with the presence of meconium release.
|
10 hours
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Moment of Rupture of the Chorioamniorex Between the Groups.
Časové okno: 10 hours
|
Observe if the groups had different types of cervical obstetric dilatation when a chorioamniorexis occurred.
|
10 hours
|
Incidence in the Type of Delivery (Cesarean Section, Normal Delivery With Laceration, Episiotomy, Forceps and Normal Delivery).
Časové okno: 10 hours
|
Type of delivery (cesarean section, normal delivery with laceration, episiotomy, forceps and normal delivery), collected by the partograph found in the medical record.
|
10 hours
|
Number of Puerperal Women Who Present Hemorrhage in the Immediate Puerperium With Hemodynamic Repercussions Between Groups.
Časové okno: immediately postpartum up to 2 days after childbirth
|
Evaluate and compare the presence of hemorrhage with hemodynamic repercussions between groups (requiring surgical approach and / or blood transfusion)
|
immediately postpartum up to 2 days after childbirth
|
The Number of Puerperal Infections Between Groups.
Časové okno: immediately postpartum up to 2 days after childbirth
|
Analyze and compare between the groups the number of puerperal infection
|
immediately postpartum up to 2 days after childbirth
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Alessandra C Marcolin, Professor, Faculty of Medicine of São Paulo University
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- FR444841
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Bolest
-
Karaman Training and Research HospitalDokončeno
-
Ajou University School of MedicineNábor
-
Beijing Tiantan HospitalZatím nenabírámeDexamethason | Torakoskopická chirurgie | Rebound Pain | Mezižeberní nervový blokČína
-
The First Affiliated Hospital of Xiamen UniversityNáborRebound Pain | Artroskopická operace kolena | OliceridinČína
-
University Hospital of North NorwayNeznámýRefered PainNorsko
-
Hospital Universitario Doctor PesetNáborAmbulantní chirurgie | Operace nohou | Rebound Pain | Blok sedacího nervuŠpanělsko
-
East Carolina UniversityStaženo
-
Quiropraxia y EquilibrioUniversidad Nacional Andres BelloDokončenoMyofascial Trigger Point Pain (MTrP)Chile
-
Quiropraxia y EquilibrioZatím nenabírámeMyofascial Trigger Point Pain (MTrP)Chile
-
Western Galilee Hospital-NahariyaDokončenoVulvodynia | Refered PainIzrael
Klinické studie na Other: Routine care
-
Chunrui LiNanjing IASO Biotechnology Co., LtdNáborStudie CAR-GPRC5D u pacientů s relapsem/refrakterním mnohočetným myelomem nebo plazmatickou leukémiíPlazmabuněčná leukémie | Recidivující/refrakterní mnohočetný myelomČína
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityDokončenoRefrakterní difúzní velký B-buněčný lymfomČína
-
Daniel LandiUkončenoGlioblastom | GliosarkomSpojené státy
-
Nexcella Inc.Zatím nenabírámeAmyloidóza lehkého řetězce (AL).Spojené státy
-
Second Affiliated Hospital, School of Medicine,...NáborRecidivující a refrakterní B-buněčný lymfomČína
-
Second Affiliated Hospital, School of Medicine,...NáborB-buněčný non Hodgkinův lymfomČína
-
Hebei Senlang Biotechnology Inc., Ltd.NáborLymfom | Mnohočetný myelom | Akutní lymfoblastická leukémieČína
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...StaženoAkutní lymfoblastická leukémie | Non-hodgkinský lymfomSpojené státy
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalNáborStudie CAR-GPRC5D u pacientů s relapsem/refrakterním mnohočetným myelomem nebo plazmatickou leukémiíPlazmabuněčná leukémie | Recidivující/refrakterní mnohočetný myelomČína
-
Southwest Hospital, ChinaNeznámýLymfom, velký B-buňka, difuzníČína